纳洛酮抑制洛哌丁胺的止泻活性。
Naloxone inhibits the anti-diarrhoeal activity of loperamide.
作者信息
Piercey M F, Ruwart M J
出版信息
Br J Pharmacol. 1979 Jul;66(3):373-5. doi: 10.1111/j.1476-5381.1979.tb10840.x.
Abstract
1 Subcutaneous prostaglandin E2 (2.5 mg/kg) produces profuse diarrhoea in fed rats. 2 Pretreatment of rats with subcutaneous loperamide (1.0 mg/kg) completely prevents prostaglandin-induced diarrhoea. If naloxone is administered prior to loperamide injections the activity of the antidiarrhoeal compound is completely destroyed. 3 These data provide strong evidence that the antidiarrhoeal activity of loperamide is mediated via the opiate receptor.
摘要
- 皮下注射前列腺素E2（2.5毫克/千克）会使喂食的大鼠出现大量腹泻。2. 用皮下注射洛哌丁胺（1.0毫克/千克）对大鼠进行预处理可完全预防前列腺素引起的腹泻。如果在注射洛哌丁胺之前给予纳洛酮，止泻化合物的活性会被完全破坏。3. 这些数据提供了强有力的证据，表明洛哌丁胺的止泻活性是通过阿片受体介导的。
相似文献
1
Naloxone inhibits the anti-diarrhoeal activity of loperamide.纳洛酮抑制洛哌丁胺的止泻活性。
Br J Pharmacol. 1979 Jul;66(3):373-5. doi: 10.1111/j.1476-5381.1979.tb10840.x.
2
The effect of loperamide on prostaglandin induced diarrhoea in rat and man.洛哌丁胺对大鼠和人体中前列腺素诱导腹泻的影响。
Prostaglandins. 1977 Feb;13(2):321-31. doi: 10.1016/0090-6980(77)90011-9.
3
Naloxone prevents loperamide inhibition of neurotransmitter induced contractions in rat vas deferens.
Cell Mol Biol. 1983;29(5):363-6.
4
Antidiarrhoeal activity of loperamide: studies of its influence on ion transport across rabbit ileal mucosa in vitro.洛哌丁胺的止泻活性：其对兔回肠黏膜离子转运体外影响的研究
Gut. 1982 Nov;23(11):974-9. doi: 10.1136/gut.23.11.974.
5
Loperamide: studies on its mechanism of action.洛哌丁胺：其作用机制的研究
Gut. 1981 Aug;22(8):658-62. doi: 10.1136/gut.22.8.658.
6
Oral naloxone antagonizes loperamide-induced delay of orocecal transit.口服纳洛酮可拮抗洛哌丁胺引起的口盲肠转运延迟。
Dig Dis Sci. 1987 Aug;32(8):829-32. doi: 10.1007/BF01296704.
7
Role of tachykinins in castor oil diarrhoea in rats.速激肽在蓖麻油所致大鼠腹泻中的作用
Br J Pharmacol. 1997 Jun;121(3):375-80. doi: 10.1038/sj.bjp.0701130.
8
The influence of morphine, loperamide and naloxone on gallbladder response to prostaglandin E2 in the anaesthetized cat.吗啡、洛哌丁胺和纳洛酮对麻醉猫胆囊对前列腺素E2反应的影响。
Acta Physiol Scand. 1986 Jul;127(3):275-9. doi: 10.1111/j.1748-1716.1986.tb07906.x.
9
Antidiarrhoeal activity of new thiazolidinones related to loperamide.与洛哌丁胺相关的新型噻唑烷二酮类化合物的止泻活性
J Pharm Pharmacol. 1996 Jul;48(7):760-2. doi: 10.1111/j.2042-7158.1996.tb03966.x.
10
Increase of plasma corticosterone induced by loperamide in rats.
Eur J Pharmacol. 1982 Apr 8;79(1-2):101-4. doi: 10.1016/0014-2999(82)90579-9.
引用本文的文献
1
Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation.naldemedine 的药理作用，一种外周作用的 μ 阿片受体拮抗剂，在阿片类药物引起的便秘的体外和体内模型中。
Neurogastroenterol Motil. 2019 May;31(5):e13563. doi: 10.1111/nmo.13563. Epub 2019 Feb 28.
2
Subcutaneous loperamide prevents gastric lesions induced by necrotizing agents in rats.皮下注射洛哌丁胺可预防大鼠坏死剂诱导的胃损伤。
Dig Dis Sci. 1997 Dec;42(12):2560-5. doi: 10.1023/a:1018876915337.
3
Difenoxin and loperamide: studies on possible mechanisms of intestinal antisecretory action.地芬诺辛与洛哌丁胺：肠道抗分泌作用可能机制的研究
Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb;347(2):231-7. doi: 10.1007/BF00169273.
4
Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro.洛哌丁胺在豚鼠结肠黏膜μ-阿片受体上的体外意外促分泌作用成分。
Br J Pharmacol. 1995 Feb;114(4):739-44. doi: 10.1111/j.1476-5381.1995.tb13266.x.
5
Inhibitors of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat.一氧化氮合酶抑制剂可预防蓖麻油诱导的大鼠腹泻。
Br J Pharmacol. 1993 Apr;108(4):861-4. doi: 10.1111/j.1476-5381.1993.tb13478.x.
6
Local inhibition of myoelectrical activity of human colon by loperamide.洛哌丁胺对人结肠肌电活动的局部抑制作用。
Dig Dis Sci. 1984 Mar;29(3):232-8. doi: 10.1007/BF01296257.
7
The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat.洛哌丁胺对大鼠前列腺素诱导的肠道分泌的抑制作用。
Br J Pharmacol. 1981 Nov;74(3):563-9. doi: 10.1111/j.1476-5381.1981.tb10465.x.
8
Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat.介导对大鼠小肠中血管活性肠肽诱导分泌的抑制作用的阿片受体群体的特征分析。
Br J Pharmacol. 1983 Oct;80(2):371-6. doi: 10.1111/j.1476-5381.1983.tb10043.x.
9
Loperamide inhibits gallbladder inflammatory fluid secretion in experimental cholecystitis.洛哌丁胺可抑制实验性胆囊炎中胆囊炎性液体的分泌。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Jun;333(2):178-81. doi: 10.1007/BF00506523.
10
Stimulation of gastrointestinal motility by loperamide in dogs.洛哌丁胺对犬胃肠道蠕动的刺激作用。
Dig Dis Sci. 1987 Jun;32(6):641-6. doi: 10.1007/BF01296165.
本文引用的文献
1
2
3
Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions.对产生和主观体验到的辨别性刺激的药物的研究。2. 洛哌丁胺，一种不产生麻醉提示作用的止泻药。
Life Sci. 1975 Mar 1;16(5):717-27. doi: 10.1016/0024-3205(75)90348-3.
4
The effect of loperamide on prostaglandin induced diarrhoea in rat and man.洛哌丁胺对大鼠和人体中前列腺素诱导腹泻的影响。
Prostaglandins. 1977 Feb;13(2):321-31. doi: 10.1016/0090-6980(77)90011-9.
5
On the antidiarrhoeal and analgesic properties of diphenoxylate, difenoxine and loperamide in mice and rats.
Arzneimittelforschung. 1977;27(5):1040-3.
6
The pharmacology of SC-27166: a novel antidiarrheal agent.新型止泻药SC-27166的药理学
J Pharmacol Exp Ther. 1977 Dec;203(3):512-26.
7
Prostaglandin-induced diarrhoea treated with loperamide or diphenoxylate. A double-blind study.用洛哌丁胺或地芬诺酯治疗前列腺素诱导的腹泻。一项双盲研究。
Acta Med Scand. 1977;202(6):449-54. doi: 10.1111/j.0954-6820.1977.tb16863.x.
8
Interaction of loperamide with [3H]naloxone binding sites in guinea pig brain and myenteric plexus.洛哌丁胺与豚鼠脑和肠肌丛中[³H]纳洛酮结合位点的相互作用。
Mol Pharmacol. 1977 May;13(3):533-40.
9
Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs.
Eur J Pharmacol. 1977 Dec 1;46(3):199-205. doi: 10.1016/0014-2999(77)90334-x.
10
Loperamide binding to opiate receptor sites of brain and myenteric plexus.洛哌丁胺与脑和肌间神经丛的阿片受体位点结合。
J Pharmacol Exp Ther. 1976 Oct;199(1):131-40.
Zotero 插件